AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
INFECTION-CONTROL CONCEPTS IN CRITICAL CARE
Authors: DIECKHAUS KD COOPER BW
Citation: Kd. Dieckhaus et Bw. Cooper, INFECTION-CONTROL CONCEPTS IN CRITICAL CARE, Critical care clinics, 14(1), 1998, pp. 55
OCCULT TUMOR CONTAMINATION OF HEMATOPOIETIC STEM-CELL PRODUCTS DOES NOT AFFECT CLINICAL OUTCOME OF AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: COOPER BW MOSS TJ ROSS AA YBANEZ J LAZARUS HM
Citation: Bw. Cooper et al., OCCULT TUMOR CONTAMINATION OF HEMATOPOIETIC STEM-CELL PRODUCTS DOES NOT AFFECT CLINICAL OUTCOME OF AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(11), 1998, pp. 3509-3517
AUTOLOGOUS CD34(- EFFECTS OF OVERNIGHT STORAGE ON PERIPHERAL-BLOOD PROGENITOR-CELL ENRICHMENT AND ENGRAFTMENT() CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED LYMPHOMA )
Authors: KOC ON GERSON SL PHILLIPS GL COOPER BW KUTTEH L VANZANT G REECE DE FOX RM SCHUPP JE TAINER N LAZARUS HM
Citation: On. Koc et al., AUTOLOGOUS CD34(- EFFECTS OF OVERNIGHT STORAGE ON PERIPHERAL-BLOOD PROGENITOR-CELL ENRICHMENT AND ENGRAFTMENT() CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED LYMPHOMA ), Bone marrow transplantation, 21(4), 1998, pp. 337-343
ERYTHROID BURST-FORMING UNITS (BFU-E) PREDICT HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: COOPER BW MACKAY W GERSON SL LAZARUS HM
Citation: Bw. Cooper et al., ERYTHROID BURST-FORMING UNITS (BFU-E) PREDICT HEMATOPOIETIC RECOVERY AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Bone marrow transplantation, 19(11), 1997, pp. 1089-1094
CULTURE-EXPANDED AUTOLOGOUS HUMAN MESENCHYMAL STEM-CELLS (MSCS) CIRCULATE IN BLOOD AND RETAIN PROLIFERATIVE CAPACITY FOLLOWING IV INFUSION INTO BREAST-CANCER PATIENTS
Authors: KOC ON DYHOUSE SM GERSON SL HAYNESWORTH SE COOPER BW KUTTEH L CAPLAN A LAZARUS HM
Citation: On. Koc et al., CULTURE-EXPANDED AUTOLOGOUS HUMAN MESENCHYMAL STEM-CELLS (MSCS) CIRCULATE IN BLOOD AND RETAIN PROLIFERATIVE CAPACITY FOLLOWING IV INFUSION INTO BREAST-CANCER PATIENTS, Blood, 90(10), 1997, pp. 1637-1637
CEFOPERAZONE SULBACTAM VERSUS CEFOPERAZONE PLUS MEZLOCILLIN - EMPIRICTHERAPY FOR FEBRILE, NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS/
Authors: LAZARUS HM CREGER RJ GUCALP R FOX RM CIOBANU N CARLISLE PS COOPER BW JACOBS MR
Citation: Hm. Lazarus et al., CEFOPERAZONE SULBACTAM VERSUS CEFOPERAZONE PLUS MEZLOCILLIN - EMPIRICTHERAPY FOR FEBRILE, NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS/, International journal of antimicrobial agents, 7(2), 1996, pp. 85-91
PHASE I II STUDY OF COMBINED GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTRATION FOR THE MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS/
Authors: WINTER JN LAZARUS HM RADEMAKER A VILLA M MANGAN C TALLMAN M JAHNKE L GORDON L NEWMAN S BYRD K COOPER BW HORVATH N CRUM E STADTMAUER EA CONKLIN E BAUMAN A MARTIN J GOOLSBY C GERSON SL BENDER J OGORMAN M
Citation: Jn. Winter et al., PHASE I II STUDY OF COMBINED GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTRATION FOR THE MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS/, Journal of clinical oncology, 14(1), 1996, pp. 277-286
SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE OF CONJUNCTIVAE AFTER ALLOGENEIC BLOOD PROGENITOR-CELL INFUSION
Authors: SPIRO TP ODAY DG BARDENSTEIN D COOPER BW LAZARUS HM
Citation: Tp. Spiro et al., SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE OF CONJUNCTIVAE AFTER ALLOGENEIC BLOOD PROGENITOR-CELL INFUSION, Bone marrow transplantation, 17(6), 1996, pp. 1179-1180
LAPAROSCOPIC LIVER-BIOPSY TO EVALUATE HEPATIC-DYSFUNCTION IN PATIENTSWITH HEMATOLOGIC MALIGNANCIES - A USEFUL TOOL TO EFFECT CHANGES IN MANAGEMENT
Authors: IQBAL M CREGER RJ FOX RM COOPER BW JACOBS G STELLATO TA LAZARUS HM
Citation: M. Iqbal et al., LAPAROSCOPIC LIVER-BIOPSY TO EVALUATE HEPATIC-DYSFUNCTION IN PATIENTSWITH HEMATOLOGIC MALIGNANCIES - A USEFUL TOOL TO EFFECT CHANGES IN MANAGEMENT, Bone marrow transplantation, 17(4), 1996, pp. 655-662
DELAYED, TRANSIENT ENCEPHALOPATHY AFTER MARROW TRANSPLANTATION - CASE-REPORTS AND MRI FINDINGS IN 4 PATIENTS
Authors: TAHSILDAR HI REMLER BF CREGER RJ COOPER BW SNODGRASS SM TARR RW LAZARUS HM
Citation: Hi. Tahsildar et al., DELAYED, TRANSIENT ENCEPHALOPATHY AFTER MARROW TRANSPLANTATION - CASE-REPORTS AND MRI FINDINGS IN 4 PATIENTS, Journal of neuro-oncology, 27(3), 1996, pp. 241-250
EFFICACY OF VANCOMYCIN AND TEICOPLANIN ALONE AND IN COMBINATION WITH STREPTOMYCIN IN EXPERIMENTAL, LOW-LEVEL VANCOMYCIN-RESISTANT, VANB-TYPE ENTEROCOCCUS-FAECALIS ENDOCARDITIS
Authors: NICOLAU DP MARANGOS MN NIGHTINGALE CH PATEL KB COOPER BW QUINTILIANI R COURVALIN P QUINTILIANI R
Citation: Dp. Nicolau et al., EFFICACY OF VANCOMYCIN AND TEICOPLANIN ALONE AND IN COMBINATION WITH STREPTOMYCIN IN EXPERIMENTAL, LOW-LEVEL VANCOMYCIN-RESISTANT, VANB-TYPE ENTEROCOCCUS-FAECALIS ENDOCARDITIS, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 55-60
ACUTE CHOLECYSTITIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA
Authors: KUTTAH L WEBER F CREGER RJ FOX RM COOPER BW JACOBS G LAZARUS HM
Citation: L. Kuttah et al., ACUTE CHOLECYSTITIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA, Annals of oncology, 6(3), 1995, pp. 302-304
IMMUNIZATION WITH HIGH-DOSE INTRADERMAL RECOMBINANT HEPATITIS-B VACCINE IN HEALTH-CARE WORKERS WHO FAILED TO RESPOND TO INTRAMUSCULAR VACCINATION
Authors: LEVITZ RE COOPER BW REGAN HC
Citation: Re. Levitz et al., IMMUNIZATION WITH HIGH-DOSE INTRADERMAL RECOMBINANT HEPATITIS-B VACCINE IN HEALTH-CARE WORKERS WHO FAILED TO RESPOND TO INTRAMUSCULAR VACCINATION, Infection control and hospital epidemiology, 16(2), 1995, pp. 88-91
MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE
Authors: FIELDS KK ELFENBEIN GJ LAZARUS HM COOPER BW PERKINS JB CREGER RJ BALLESTER OF HIEMENZ JH JANSSEN WE ZORSKY PE
Citation: Kk. Fields et al., MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE, Journal of clinical oncology, 13(2), 1995, pp. 323-332
PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER
Authors: LAZARUS HM WINTON EF WILLIAMS SF GRINBLATT D CAMPION M COOPER BW GUNN H MANFREDA S ISAACS RE
Citation: Hm. Lazarus et al., PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER, Bone marrow transplantation, 15(6), 1995, pp. 935-942
PROGENITOR CONTENT AND CD34-BLOOD PROGENITOR-CELL (PBPC) COLLECTIONS ARE BETTER PREDICTORS OF HEMATOPOIETIC RECOVERY THAN TOTAL MONONUCLEARCELL (MNC) COUNT( CELLS IN PERIPHERAL)
Authors: KOC ON LAZARUS HM COOPER BW STECKLEY JA GERSON SL
Citation: On. Koc et al., PROGENITOR CONTENT AND CD34-BLOOD PROGENITOR-CELL (PBPC) COLLECTIONS ARE BETTER PREDICTORS OF HEMATOPOIETIC RECOVERY THAN TOTAL MONONUCLEARCELL (MNC) COUNT( CELLS IN PERIPHERAL), Blood, 86(10), 1995, pp. 3929-3929
THE INCIDENCE OF TUMOR CONTAMINATION IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC)
Authors: MOSS TJ PECORA A COOPER BW LAZARUS HM KAHN D GLASGOW J
Citation: Tj. Moss et al., THE INCIDENCE OF TUMOR CONTAMINATION IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA (SCLC), Blood, 86(10), 1995, pp. 3946-3946
HEPATIC-DYSFUNCTION IN PATIENTS WITH CARCINOMA WHO ARE SEVERELY THROMBOCYTOPENIC AND IMMUNOSUPPRESSED
Authors: LAZARUS HM CREGER RJ FOX RM COOPER BW JACOBS G STELLATO TA
Citation: Hm. Lazarus et al., HEPATIC-DYSFUNCTION IN PATIENTS WITH CARCINOMA WHO ARE SEVERELY THROMBOCYTOPENIC AND IMMUNOSUPPRESSED, Journal of the American College of Surgeons, 179(4), 1994, pp. 433-439
AN INFLAMMATORY ERUPTION ASSOCIATED WITH RECOMBINANT HUMAN IL-6
Authors: FLEMING TE MIRANDO WS SOOHOO LF COOPER BW ZAIM MT LAZARUS HM ELMETS CA
Citation: Te. Fleming et al., AN INFLAMMATORY ERUPTION ASSOCIATED WITH RECOMBINANT HUMAN IL-6, British journal of dermatology, 130(4), 1994, pp. 534-536
SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I II MULTICENTER STUDY/
Authors: FAY JW LAZARUS H HERZIG R SAEZ R STEVENS DA COLLINS RH PINEIRO LA COOPER BW DICESARE J CAMPION M FELSER JM HERZIG G BERNSTEIN SH
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I II MULTICENTER STUDY/, Blood, 84(7), 1994, pp. 2151-2157
COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES
Authors: CRILLEY P LAZARUS H TOPOLSKY D CIOBANU N CREGER RJ FOX RM BULOVA SI SHINA DC GUCALP R COOPER BW SOEGIARSO W STYLER M BRODSKY I
Citation: P. Crilley et al., COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES, Seminars in oncology, 20(4), 1993, pp. 50-54
DETECTION AND VIABILITY OF TUMOR-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM BREAST-CANCER PATIENTS USING IMMUNOCYTOCHEMICAL AND CLONOGENIC-ASSAY TECHNIQUES
Authors: ROSS AA COOPER BW LAZARUS HM MACKAY W MOSS TJ CIOBANU N TALLMAN MS KENNEDY MJ DAVIDSON NE SWEET D WINTER C AKARD L JANSEN J COPELAN E MEAGHER RC HERZIG RH KLUMPP TR KAHN DG WARNER NE
Citation: Aa. Ross et al., DETECTION AND VIABILITY OF TUMOR-CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM BREAST-CANCER PATIENTS USING IMMUNOCYTOCHEMICAL AND CLONOGENIC-ASSAY TECHNIQUES, Blood, 82(9), 1993, pp. 2605-2610
PHASE-1 STUDY OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6, ESCHERICHIA-COLI) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN PATIENTS WITHPOOR-PROGNOSIS BREAST-CANCER
Authors: LAZARUS HM WINTON EF WILLIAMS SF GRINBLATT D CAMPION M MANFREDA S COOPER BW ISAACS RE
Citation: Hm. Lazarus et al., PHASE-1 STUDY OF RECOMBINANT HUMAN INTERLEUKIN-6 (RHIL-6, ESCHERICHIA-COLI) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN PATIENTS WITHPOOR-PROGNOSIS BREAST-CANCER, Blood, 82(10), 1993, pp. 10000173-10000173
CONCOMITANT ADMINISTRATION OF INTERLEUKIN-6 (RHIL-6) AND LEUCOMAX(R) (RHGM-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION-A PHASE-I TRAIL
Authors: FAY JW COLLINS R PINEIRO L DUTCHER J GUCALP R GRINBLATT D LAZARUS HM WILLIAMS S COOPER BW MANFREDA S ISAACS R
Citation: Jw. Fay et al., CONCOMITANT ADMINISTRATION OF INTERLEUKIN-6 (RHIL-6) AND LEUCOMAX(R) (RHGM-CSF) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION-A PHASE-I TRAIL, Blood, 82(10), 1993, pp. 10000431-10000431
IMPACT OF OCCULT TUMOR-CELL CONTAMINATION (OT) OF STEM-CELL AUTOGRAFTON RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY (HDC) IN PATIENTS WITH STAGE-IV BREAST-CANCER (BC)
Authors: COOPER BW ROSS A LAZARUS HM
Citation: Bw. Cooper et al., IMPACT OF OCCULT TUMOR-CELL CONTAMINATION (OT) OF STEM-CELL AUTOGRAFTON RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY (HDC) IN PATIENTS WITH STAGE-IV BREAST-CANCER (BC), Blood, 82(10), 1993, pp. 10000629-10000629
Risultati: 1-25 | 26-27